Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Carcinoma, Hepatocellular 6 Adenocarcinoma 6 Neoplasms 5 Lung Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Urethral Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Ureteral Neoplasms 2 Solid Tumors 2 Sarcoma 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Thymoma 1 Solid Tumor 1 Sarcoma, Synovial 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

tusamitamab ravtansine 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Adenocarcinoma Gastric × Ramucirumab × Clear all

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated

35 enrolled 14 charts

Gastrointestinal

Adenocarcinoma Gastric

Data powered by HemOnc (CC BY 4.0) Colophon ⚡